Tower Cold Chain Announces Two New Senior Appointments

News
Article

Karin Van Den Brekel, Niall Walsh hired to manage EMEA and Ireland respectively.

Karin Van Den Brekel

Karin Van Den Brekel

Tower Cold Chain—a company that rents containers to the pharma industry for temperature-specific transport—has continued the expansion of its global team with the appointment of a regional commercial manager for Europe, Middle East, and Africa (EMEA) and a business development manager for Ireland.

Karin Van Den Brekel joins Tower as regional commercial manager in the EMEA region. Key to nurturing collaborative partnerships with pharmaceutical manufacturers, airlines, and third-party logistics providers (3PLs) in Europe, the Middle East and Africa, she brings senior commercial leadership experience in global business development to the team. Previously director of business development at SkyCell AG, driving sales growth across pharma and biotech customers, Van Den Brekel brings industry experience working for FedEx, XPO, and TNT. She will also be working alongside Tower's existing regional operations manager EMEA, Marloes Wanrooij, to support new and existing customers in the region.

In addition, Niall Walsh, the new business development manager in Ireland, will be responsible for delivering growth within Northern Ireland and for supporting existing customers in their temperature-sensitive shipments across the region. He has extensive proficiency working within the biopharma industry bringing 15+ years of knowledge and contacts to support customer needs in the Irish market.

“We are delighted to welcome Karin and Niall to Team Tower, whose combined expertise complements the exceptional service we already offer,” comments Niall Balfour, Tower Cold Chain. “At Tower Cold Chain, we pride ourselves in maintaining exceptionally high standards in every product and service we offer, so it is crucial we bring regional and local specialists into the team.”

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.